These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16183285)

  • 41. Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer's disease.
    Rodríguez-Lavado J; Gallardo-Garrido C; Mallea M; Bustos V; Osorio R; Hödar-Salazar M; Chung H; Araya-Maturana R; Lorca M; Pessoa-Mahana CD; Mella-Raipán J; Saitz C; Jaque P; Reyes-Parada M; Iturriaga-Vásquez P; Pessoa-Mahana H
    Eur J Med Chem; 2020 Jul; 198():112368. PubMed ID: 32388114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons.
    Kittler K; Lau T; Schloss P
    Eur J Pharmacol; 2010 Mar; 629(1-3):63-7. PubMed ID: 20006597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: characterisation of its in vitro profile and pre-clinical antipsychotic potential.
    Hertel P; Didriksen M; Pouzet B; Brennum LT; Søby KK; Larsen AK; Christoffersen CT; Ramirez T; Marcus MM; Svensson TH; Di Matteo V; Esposito E; Bang-Andersen B; Arnt J
    Eur J Pharmacol; 2007 Nov; 573(1-3):148-60. PubMed ID: 17689529
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.
    Gabrielsen M; Kurczab R; Ravna AW; Kufareva I; Abagyan R; Chilmonczyk Z; Bojarski AJ; Sylte I
    Eur J Med Chem; 2012 Jan; 47(1):24-37. PubMed ID: 22071255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biotin tethered homotryptamine derivatives: high affinity probes of the human serotonin transporter (hSERT).
    Tomlinson ID; Iwamoto H; Blakely RD; Rosenthal SJ
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1678-82. PubMed ID: 21334895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ; Chodkowski A; Herold F; Gomółka A; Kleps J; Mazurek AP; Pluciński F; Mazurek A; Nowak G; Siwek A; Stachowicz K; Sławińska A; Wolak M; Szewczyk B; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2013 May; 63():484-500. PubMed ID: 23524160
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homotryptamines as potent and selective serotonin reuptake inhibitors (SSRIs).
    Schmitz WD; Denhart DJ; Brenner AB; Ditta JL; Mattson RJ; Mattson GK; Molski TF; Macor JE
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1619-21. PubMed ID: 15745809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
    J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT
    Walory J; Mielczarek L; Jarończyk M; Koronkiewicz M; Kossakowski J; Bugno R; Bojarski AJ; Chilmonczyk Z
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.
    Evrard DA; Zhou P; Yi SY; Zhou D; Smith DL; Sullivan KM; Hornby GA; Schechter LE; Andree TH; Mewshaw RE
    Bioorg Med Chem Lett; 2005 Feb; 15(4):911-4. PubMed ID: 15686885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect.
    Wróbel MZ; Chodkowski A; Herold F; Marciniak M; Dawidowski M; Siwek A; Starowicz G; Stachowicz K; Szewczyk B; Nowak G; Belka M; Bączek T; Satała G; Bojarski AJ; Turło J
    Eur J Med Chem; 2019 Dec; 183():111736. PubMed ID: 31586817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors.
    Denhart DJ; Deskus JA; Ditta JL; Gao Q; Dalton King H; Kozlowski ES; Meng Z; LaPaglia MA; Mattson GK; Molski TF; Taber MT; Lodge NJ; Mattson RJ; Macor JE
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4031-3. PubMed ID: 19560923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
    Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
    Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.
    Hatzenbuhler NT; Baudy R; Evrard DA; Failli A; Harrison BL; Lenicek S; Mewshaw RE; Saab A; Shah U; Sze J; Zhang M; Zhou D; Chlenov M; Kagan M; Golembieski J; Hornby G; Lai M; Smith DL; Sullivan KM; Schechter LE; Andree TH
    J Med Chem; 2008 Nov; 51(21):6980-7004. PubMed ID: 18834188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, monoamine transporter binding, properties, and functional monoamine uptake activity of 3beta-[4-methylphenyl and 4-chlorophenyl]-2 beta-[5-(substituted phenyl)thiazol-2-yl]tropanes.
    Gong PK; Blough BE; Brieaddy LE; Huang X; Kuhar MJ; Navarro HA; Carroll FI
    J Med Chem; 2007 Jul; 50(15):3686-95. PubMed ID: 17602602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors.
    Degnan AP; Tora GO; Han Y; Rajamani R; Bertekap R; Krause R; Davis CD; Hu J; Morgan D; Taylor SJ; Krause K; Li YW; Mattson G; Cunningham MA; Taber MT; Lodge NJ; Bronson JJ; Gillman KW; Macor JE
    Bioorg Med Chem Lett; 2015 Aug; 25(15):3039-43. PubMed ID: 26048800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
    Bang-Andersen B; Ruhland T; Jørgensen M; Smith G; Frederiksen K; Jensen KG; Zhong H; Nielsen SM; Hogg S; Mørk A; Stensbøl TB
    J Med Chem; 2011 May; 54(9):3206-21. PubMed ID: 21486038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.
    Heinrich T; Böttcher H; Gericke R; Bartoszyk GD; Anzali S; Seyfried CA; Greiner HE; Van Amsterdam C
    J Med Chem; 2004 Sep; 47(19):4684-92. PubMed ID: 15341484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluorescent mimics of 5-hydroxytryptamine based on N-alkylated derivatives of 6-hydroxycarbostyril.
    Micotto TL; Brown AS; Wilson JN
    Chem Commun (Camb); 2009 Dec; (48):7548-50. PubMed ID: 20024275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.